The therapeutic response of ER+/HER2- breast cancers differs according to the molecular Basal or Luminal subtype. [electronic resource]
Publication details: NPJ breast cancer 2020Description: 8 p. digitalISSN:- 2374-4677
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.